Table 3.
Results of quantitative analysis
| Subgroup | HR | 95% CI | I2 (%) | PH |
|---|---|---|---|---|
| OS | ||||
| Overall | 1.18 | 0.98-1.43 | 74.1 | <0.001 |
| Member type | ||||
| miR-141 | 1.58 | 0.78-3.19 | 64.1 | 0.061 |
| miR-200a | 0.78 | 0.29-2.09 | 88.4 | 0.003 |
| miR-200b | 0.76 | 0.30-1.79 | 92.3 | <0.001 |
| miR-200c | 1.59 | 1.09-2.34 | 63.3 | 0.043 |
| miR-429 | 1.17 | 0.60-2.30 | 79.1 | 0.002 |
| Location | ||||
| Asia | 2.06 | 1.58-2.68 | 0 | 0.71 |
| Europe | 1.11 | 0.99-1.26 | 46.8 | 0.094 |
| America | 0.56 | 0.33-0.91 | 40.5 | 0.186 |
| Sample type | ||||
| Plasma | 1.23 | 1.08-1.41 | 52.3 | 0.033 |
| Tumor tissues | 0.92 | 0.44-1.94 | 83.9 | <0.001 |
| RFS | ||||
| Overall | 1.13 | 1.04-1.23 | 0 | 0.446 |
| Member type | ||||
| miR-200c | 1.15 | 0.98-1.35 | 59.4 | 0.085 |
| Location | ||||
| Asia | 2.39 | 1.20-4.77 | 0 | 0.549 |
| Europe | 1.12 | 1.03-1.21 | 0 | 0.931 |
| Sample type | ||||
| Plasma | 1.12 | 1.03-1.21 | 0 | 0.549 |
| Tumor tissues | 2.39 | 1.20-4.77 | 0 | 0.931 |